Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Magna Investama Mandiri Tbk. (MGNA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Magna Investama Mandiri Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Magna Investama Mandiri Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Magna Investama Mandiri Tbk. trades at Rp99 (market cap 351.35B, 12.84M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Magna Investama Mandiri Tbk. is far larger — about 2.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Magna Investama Mandiri Tbk. is more actively traded (12.84M versus 62.5K). Which is the better fit depends on your goals.

MGNAOBAT
Market Cap
351.35B164.65B
Volume
12.84M62.5K
Lot
128.42K625
Turnover
1.35B15.03M
Average Price
104.98240.55
Value
1.35B15.03M
Indicative Equilibrium Price
99238
Indicative Equilibrium Volume
288100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MGNA
View details
OBAT
View details

About Magna Investama Mandiri Tbk.

PT Magna Finance Tbk (the Company) formerly PT Arkasa Utama Leasing was established based on Notarial Deed No. 10 dated March 09, 1984 of James Jacinta Susanti, S.H.

Read more on MGNA

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT